Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance

CompletedOBSERVATIONAL

Enrollment

215

Participants

Timeline

Start Date

January 27, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

TuberculosisNon-Tuberculosis Mycobacteria

Trial Locations (2)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Henan Provincial Chest Hospital, Zhengzhou

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02534727 - Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance | Biotech Hunter | Biotech Hunter